Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has recalled around 2,839 bottles of anti-bacterial medicine Nitrofurantoin Oral Suspension in the US market on account of failed dissolution specifications. The ongoing voluntary recall by Nostrum Laboratories for Nitrofurantoin Oral Suspension, USP, 25 mg/5 mL is a class II recall. The 2,839 bottles were manufactured and distributed by Sun Pharmaceutical Industries. 

According to USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. Nitrofurantoin oral suspension, USP is specifically indicated for the treatment of urinary tract infections.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world.